The global esophageal cancer market is expanding due to a
rise in undiagnosed achalasia cases, which can potentially lead to
esophageal cancer.
WILMINGTON, Del., July 16,
2024 /PRNewswire/ -- The global esophageal cancer
market stood at US$ 2.2
billion in 2023, and the global market is projected
to reach US$ 4.6 billion in
2034. The esophageal cancer market is anticipated to expand at a
CAGR of 6.7% between 2024 and 2034.
The esophageal cancer market is experiencing significant growth
driven by several key factors influencing diagnosis, treatment, and
research efforts globally. Esophageal cancer, a malignancy
affecting the lining of the esophagus, poses substantial challenges
due to its often late-stage diagnosis and aggressive nature. The
market's expansion is primarily propelled by an increasing
incidence of risk factors such as smoking, heavy alcohol
consumption, and gastroesophageal reflux disease (GERD), which
heighten the likelihood of developing this cancer.
Diagnostic advancements play a crucial role in the market's
evolution, with improved imaging technologies and screening
techniques aiding in early detection. Endoscopic procedures,
including endoscopic ultrasound and biopsy, enable precise
diagnosis and staging of esophageal cancer, facilitating prompt
initiation of treatment protocols. Early detection is pivotal as it
enhances treatment outcomes and patient survival rates.
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86181
Treatment options for esophageal cancer continue to evolve,
encompassing a multimodal approach tailored to individual patient
profiles. Surgery remains a cornerstone for localized disease, with
advancements in minimally invasive techniques offering reduced
recovery times and improved outcomes. Chemotherapy and radiation
therapy are integral components, either as primary treatments or in
combination with surgery, aiming to eradicate cancer cells and
prevent recurrence.
Furthermore, the advent of targeted therapies and immunotherapy
has revolutionized esophageal cancer management. These innovative
treatments, targeting specific genetic mutations or enhancing the
body's immune response against cancer cells, provide new avenues
for patients with advanced or recurrent disease.
In the realm of research and development (R&D), ongoing
efforts focus on identifying biomarkers for early detection,
elucidating molecular pathways of esophageal cancer progression,
and refining therapeutic strategies. Clinical
trials evaluating novel drugs and treatment regimens
underscore the industry's commitment to advancing patient care and
outcomes.
Looking ahead, the esophageal cancer market is poised for
continued expansion with ongoing advancements in diagnostic
technologies, treatment modalities, and supportive care strategies.
These developments aim not only to improve survival rates and
quality of life for patients but also to address the unmet medical
needs in this challenging oncological landscape.
Esophageal Cancer Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 2.2 Bn
|
Forecast (Value) in
2034
|
US$ 4.6 Bn
|
Growth Rate
(CAGR)
|
6.7 %
|
No. of
Pages
|
195
Pages
|
Segments
covered
|
By Product Type, By
Application, By Region, By End-user
|
Key Takeaways of Market Report
• Global esophageal cancer market to generate absolute
dollar opportunity worth US$ 4.6
billion until 2034.
• Global esophageal cancer market is valued at
US$ 2.2 billion in 2023.
• North America is
forecasted to hold the largest share in 2023.
Esophageal Cancer Market: Growth Drivers
• Research indicates a familial link between Allgrove
syndrome and the heightened risk of esophageal cancer development
in affected individuals. This genetic predisposition underscores
the importance of genetic screening and early intervention to
mitigate risks associated with this primary esophageal motility
disorder.
• Immune checkpoint inhibitors, specifically programmed
cell death-1 (PD-1) antibodies, are transforming the treatment
landscape of esophageal cancer. Demonstrating promising efficacy
and acceptable safety profiles in clinical trials, ICIs are now
integrated into various stages of esophageal cancer management.
• Their ability to enhance prognosis and potentially
extend survival in patients with advanced disease marks a
significant advancement in oncological therapies, offering new hope
for improved outcomes and quality of life.
Unlock Growth Potential in Your Industry! Download PDF
Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86181
Esophageal Cancer Market: Regional Landscape
• North America
maintained its leading position in the esophageal carcinoma market,
driven by advanced healthcare infrastructure, high incidence rates,
and substantial investments in oncological research. The region's
robust clinical capabilities and adoption of cutting-edge therapies
contribute to its dominant market share.
• The Asia Pacific region
is witnessing significant growth in the esophageal cancer market,
fueled by an increase in clinical trials focused on novel
therapeutics. For example, ongoing trials evaluating combination
therapies such as induction DCF (docetaxel, cisplatin, and
5-fluorouracil) followed by definitive chemo-radiotherapy highlight
the region's commitment to advancing treatment options for locally
advanced thoracic esophageal carcinoma.
Esophageal Cancer Market: Key Players
• In 2023, Merck & Co., Inc. made significant strides
in esophageal cancer treatment with the development of
pembrolizumab (Keytruda). This immune checkpoint inhibitor targets
the PD-1 pathway and has shown promising results in clinical trials
for various cancers, including esophageal carcinoma.
• In 2023, Eli Lilly and Company focused on advancing
treatment options for esophageal cancer with their development of
ramucirumab (Cyramza). Ramucirumab is a monoclonal antibody that
targets the VEGFR-2 receptor, which plays a crucial role in
angiogenesis, the process by which tumors develop new blood
vessels.
Esophageal Cancer Market: Segmentation
Treatment Type
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Immunotherapy
• Others
Stage of Cancer
• Early-stage Esophageal Cancer
• Advanced Esophageal Cancer
End User
• Hospitals
• Specialty Clinics
• Cancer Treatment Centers
• Ambulatory Surgical Centers
Region
• North America
• Europe
• Asia Pacific
• Middle East &
Africa
• Latin America
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86181<ype=S
More Trending Reports by Transparency Market Research
–
• Cervical Cancer Diagnostic Tests
Market - The global cervical cancer diagnostic
tests market is projected to advance at a CAGR of 4.6% from
2022 to 2031
• In-vitro Colorectal Cancer Screening Tests
Market - The global In-vitro colorectal cancer
screening tests market is projected to expand at a CAGR of
7.1% during the forecast period from 2024 to 2034
• Diagnostic Dermatology Equipment
Market - The global industry, valued at
US$ 11.6 billion in 2023, is expected
to grow at a CAGR of 12.8% from 2024 to 2034, reaching US$ 43.4 billion by the end of 2034
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE
HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
View original
content:https://www.prnewswire.com/news-releases/esophageal-cancer-market-size-to-be-worth-usd-4-6-billion-by-2034--growing-at-cagr-of-6-7--exclusive-report-by-transparency-market-research-inc-302197100.html
SOURCE Transparency Market Research